Objective Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a loss of immune tolerance, affecting ...
Q4 2024 Earnings Conference Call November 21, 2024 8:00 AM ETCompany ParticipantsMatt Kline - Vice President, Treasury and ...
The pharma company raised its guidance on higher revenue expectations for key treatments and product launches, and is looking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback